Similarly, IL-17A has tumour-promoting effects mediated by promoting cancer epithelial-to-mesenchymal transition in vivo via tissue-remodelling matrix metalloproteinases (MMPs), such as MMP-2, MMP-7,and MMP-9 [7]. Here, IL17A is linked to neoplasm.